The Key Account Manager is responsible for developing and executing institutional strategies to increase disease awareness, enhance system-level partnerships, and establish sustainable screening and identification pathways for hypercortisolism across targeted integrated delivery networks (IDNs), academic medical centers, and large healthcare systems. KAMs engage a broad range of clinical and operational stakeholders including endocrinologists, diabetologists, cardiologists, neurosurgeons, endocrine surgeons, interventional radiologists, informatics leaders, quality teams, care coordination, population health, and senior system leadership.